Jeremy Duffield
Directeur Technique/Scientifique/R&D chez PRIME MEDICINE, INC.
Fortune : 4 M $ au 30/04/2024
Profil
Jeremy Duffield is currently the Chief Scientific Officer at Prime Medicine, Inc. Prior to this, he worked as the Vice President of Business Development at Vertex Pharmaceuticals, Inc. from 2018 to 2021 and as Vice President at Biogen, Inc. from 2013 to 2019.
He is also a member of the American Society of Clinical Investigation.
Dr. Duffield holds a doctorate degree from both the University of Oxford and the University of Edinburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRIME MEDICINE, INC.
0,80% | 31/03/2024 | 965 001 ( 0,80% ) | 4 M $ | 30/04/2024 |
Postes actifs de Jeremy Duffield
| Sociétés | Poste | Début |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Anciens postes connus de Jeremy Duffield
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2019 |
| American Society of Clinical Investigation | Corporate Officer/Principal | - |
Formation de Jeremy Duffield
| The University of Edinburgh | Doctorate Degree |
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| American Society of Clinical Investigation |